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 Abstract 
  Background and Purpose:  Advances in the management of acute ischemic stroke and medical 
imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and 
non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds 
used for the selection of patients eligible for intravenous thrombolytic therapy. The identifica-
tion of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, 
the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed.   Materi-
als and Methods:   We retrospectively reviewed the clinical and imaging data of 92 consecutive 
patients who received intravenous thrombolytic therapy for acute (duration   !  3 h) ischemic 
stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-
up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imag-
ing parameters. Receiver-operating characteristic curve analysis was performed to determine 
optimal thresholds for different parameters to predict clinical outcome.   Results:   A perfusion 
defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical 
outcome in the following order: follow-up NCCT   1   cerebral blood volume (CBV)  1   mean transit 
time (MTT)   1   admission NCCT. The follow-up NCCT and the CBV displayed a statistically signifi-
cant difference from the admission NCCT, while the MTT did not reach statistical significance. 
The threshold that best differentiated between good and bad clinical outcome on admission 
was CBV ASPECTS  6 7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS 
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essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining 
the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly 
correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the 
amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch ad-
equately identifies the amount of potentially salvageable ischemic brain tissue.   Conclusions:  
Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and 
are correlated with clinical outcome.    Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 The role of CT perfusion (CTP) in the decision to administer thrombolytic therapy with 
intravenous recombinant tissue plasminogen activator (rtPA) remains controversial. Re-
search initiatives have been proposed to establish a sufficient body of evidence that would 
allow formal clinical guidelines to be composed  [1] . At the core of this dilemma lie the detec-
tion of the ischemic penumbra and the infarct core and the implications this information 
should have for clinical decision making. Previous studies suggest that CTP can provide an 
estimate of the amount of potentially salvageable, acutely ischemic brain tissue and that the 
resulting CTP parameters provide an independent prognostic factor of the clinical outcome 
  [2–6] . CTP also seems to increase diagnostic performance in stroke diagnosis and inter- and 
intraobserver agreement   [7] .
  The Alberta Stroke Program Early CT Score (ASPECTS) is a semiquantitative, weighted 
scoring system that was developed to overcome the difficulties in the application of the non-
contrast-enhanced CT (NCCT) one-third middle cerebral artery (MCA) rule that is used to 
select patients eligible for intravenous thrombolytic therapy   [8]  . ASPECTS is predictive of 
clinical outcome and hemorrhagic complications but is not sufficiently accurate in the triage 
of thrombolysis candidates   [9–11]  . Applying ASPECTS to CTP parametric maps has been 
suggested to be more reliable in both detecting reversible ischemia and predicting clinical 
outcome   [12–15] .
    We retrospectively reviewed the clinical and imaging data of 92 consecutive patients 
who received intravenous thrombolytic therapy for acute (duration   !  3 h) ischemic stroke in 
order to study the potential of CTP ASPECTS in the detection of reversible ischemia. We 
hypothesized that CTP ASPECTS mismatch   [16]  , the difference between the mean transit 
time (MTT) and cerebral blood volume (CBV) map scores, might be useful in identifying 
patients who potentially benefit from thrombolytic therapy.
  Materials  and  Methods 
 Overview 
 We retrospectively analyzed the clinical and imaging data of 92 consecutive patients who 
were admitted to Tampere University Hospital between January 2007 and December 2007 
because of acute (duration   !  3 h) stroke symptoms and who received intravenous rtPA for the 
treatment of acute ischemic stroke after evaluation. In total, 271 patients suffering from acute 
ischemic stroke were evaluated as candidates for thrombolytic therapy during this period of 
time. The initial imaging evaluation of stroke patients consisted of NCCT, CT angiography 
(CTA) and CTP. The selection of patients eligible for thrombolytic therapy was based on in-
stitutional guidelines that did not have CTP or CTA parameters as exclusion or inclusion cri-
teria. Still, we reviewed patient records of 179 patients who did not receive thrombolytic ther-8
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apy in order to detect possible selection bias caused by CTP studies. The indications to exclude 
a patient from thrombolytic therapy had been carefully documented. In 1 case, the decision 
to exclude the patient was based on the results of a CTP study (extremely poor technical qual-
ity of the admission NCCT and over one third MCA lesions in the CBV map). In addition, we 
discovered 3 cases in which the admission NCCT was initially erroneously interpreted as 
negative and the results were reported orally to the stroke neurologist, followed by a review 
and a correction after the CTP maps had been calculated and analyzed some minutes later, 
with the result that the decision to administer thrombolytic therapy was withdrawn.
    A full multimodal imaging evaluation was successfully completed in 72 of the 92 pa-
tients who received thrombolytic therapy. Nine patients were evaluated with NCCT alone 
and 11 patients with NCCT and CTA because of previously known contrast agent hypersen-
sitivity, chronic renal failure, imminent closure of the 3-hour time window, or movement 
artifacts that rendered some of the imaging data not evaluable. A standard rtPA administra-
tion scheme was used: a total dose of 0.9 mg/kg Actilyse (Boehringer-Ingelheim, Ingelheim, 
Germany) was administered, with 10% given as a bolus and the remaining 90% as a contin-
uous infusion for 1 h. A follow-up NCCT was performed for all patients 24 h after the ad-
ministration of the thrombolytic agent. National Institutes of Health Stroke Scale (NIHSS) 
scores were assessed on admission and 24 h after the thrombolytic therapy. The modified 
Rankin Scale (mRS) was evaluated preictally and on day 90. The clinical data were stored 
(prospectively) in the patient records during the hospital stay and on day 90 after the ictus, 
the latter following a phone interview. These data were collected from the patient records and 
critically reviewed for errors using the data available from all medical and related disciplines 
(J.T.S.). The study was approved by the Tampere University Hospital Ethics Committee.
  Imaging  Parameters 
  CT scans were obtained using two different multidetector scanners: the General Electrics 
LightSpeed 16-slice scanner (GE Healthcare, Milwaukee, Wisc., USA) and the Philips Bril-
liance 64-slice scanner (Philips, Cleveland, Ohio, USA). Brain NCCT was performed using the 
parameters 120 kV, 430 mA, collimation 12   !   1.25 mm, and rotation 1.5 s (64-slice scanner), 
or 120 kV, 320 mA, collimation 16  !  1.25 mm, and rotation 1 s (16-slice scanner). Contiguous 
slices were reconstructed to the thickness of 5 mm in the whole scanning range (64-slice scan-
ner) or to the thickness of 5 mm in the skull base and 7.5 mm in the supratentorial region 
(16-slice scanner). CTA was performed using a scanning range extending from the C2 vertebra 
to the vertex of the skull. The imaging parameters were 120 kV, 212 mA (using dynamic tube 
current modulation), collimation 64   !   0.625 mm, rotation 0.75 s, and pitch factor 0.923 
(64-slice scanner), or 120 kV, 160 mA, collimation 16   !   0.625 mm, rotation 0.8 s, and pitch 
factor 0.938 (16-slice scanner). Contiguous slices were reconstructed to the thickness of 0.9 mm 
with a 0.45-mm overlap (64-slice scanner) or to the thickness of 1.25 mm (16-slice scanner). 
The contrast agent (iobitridol 350 mg I/ml; Xenetix, Aulnay-sous-Bois, France) was adminis-
tered via an antecubital vein with an 18-gauge cannula using a double-piston power injector 
with a flow rate of 4 ml/s and 70 ml of contrast agent followed by a 50-ml saline flush. Manu-
al bolus triggering was used. CTP was performed using the parameters 80 kV, 200 mA (effec-
tive), collimation 32   !   1.25 mm, and rotation 0.4 s (64-slice scanner), or 80 kV, 200 mA, col-
limation 8  !  2.5 mm, and rotation 1 s (16-slice scanner). 120 slices covering a range of 80 mm 
were generated in 55 s using an alternating jog protocol, i.e. shuttle mode (64-slice scanner), or 
200 slices covering a range of 20 mm were generated in 50 s with a stationary gantry position 
(16-slice scanner). Contiguous slices were reconstructed to a thickness of 10 mm (64-slice scan-
ner) or 5 mm (16-slice scanner) at even time intervals. The imaging range was positioned so 
that the ASPECTS planes  [8]  were always covered. The rest of the 80-mm range (64-slice scan-
ner) was positioned both cranial and caudal to the ASPECTS planes with the exact balancing 9
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depending on the clinical presentation. The contrast agent (Xenetix 350 mg I/ml) was admin-
istered via an antecubital vein with an 18-gauge cannula using a double-piston power injector 
with a flow rate of 5 ml/s and 60 ml of contrast agent followed by a 40-ml saline flush.
  Image  Analysis 
  NCCT examinations were reviewed using dedicated medical imaging workstations. 
CTA and CTP images were analyzed, and areas and volumes were measured with Advantage 
Workstation version 3.2 (GE Healthcare). Parametric perfusion maps – MTT, cerebral blood 
flow, and CBV – were generated with the CT Perfusion 3 software that uses a deconvolution-
based algorithm. CTA images were reviewed by examining both the raw data and maximum 
intensity projection images.
  The principles of ASPECTS scoring in NCCT and CTP maps and the evaluation of CTP 
ASPECTS mismatch have been described in previous studies  [8, 12, 15] . In short, each hemi-
sphere is divided into 10 regions in 2 axial planes at the level of the basal ganglia and corona 
radiata (  fig. 1  ). Each of these regions has a score of 1 point. This point is deducted if that re-
gion has ischemic changes. Thus, a negative finding yields a score of 10, and extensive isch-
emia covering the whole MCA region yields a score of 0.
    MTT maps were used to detect tissue at risk, and CBV maps were used to approximate 
the infarct core   [4]  . The calculation of CTP ASPECTS mismatch is described in   figure 1  . We 
adopted a semiquantitative approach where the presence of a perfusion defect was deter-
mined visually from color-coded maps by comparing the appearance of the affected location 
with that of the healthy tissue on the contralateral side. In order to increase measurement 
  Fig. 1.   CTP ASPECTS mis-
match in a patient suffering 
from acute ischemia in the right 
MCA  ter ritory. In the CBV maps, 
  ASPECTS areas I, M2, and M5 
are affected (CBV ASPECTS = 
7), whereas in the MTT maps 
  areas I, M1, M2, M4, M5, and 
M6 display a perfusion defect 
(MTT ASPECTS = 4). Thus, 
CTP   ASPECTS mismatch = 3. 10
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accuracy and based on theoretical considerations, the area in the visually identified location 
was required to measure  1 25 mm 2  with a mean MTT  1 7 s (or mean CBV  ! 2.5 ml/100 g, cor-
respondingly). NCCT and CTP ASPECTS were assigned by two radiologists (N.S. and A.L.). 
In cases where the scoring differed, a consensus score was agreed on. This score was corre-
lated with the original findings of an experienced neuroradiologist, and if significant dis-
crepancies were present, this neuroradiologist was further consulted. The examinations were 
reviewed in the order NCCT, CTA, and finally CTP, paralleling that of the clinical work flow. 
The reviewers were blinded to the clinical data apart from the side and nature of the acute 
symptoms. Perfusion defect areas and final infarct volumes were measured by one radiolo-
gist (N.S.). The boundaries of the affected areas were determined visually, and absolute val-
ue thresholds described above were applied. Volume was calculated by multiplying the mea-
sured area with the slice thickness. Intraclass correlation coefficients (ICC) between a staff 
radiologist (N.S.) and an experienced neuroradiologist (J.H.) were calculated for ASPECTS 
assignments in a test sample (n = 20): ICC  NCCT   = 0.86, ICC  MTT   = 0.79, ICC  CBV   = 0.73, and 
ICC  NCCT 24 h   = 0.93. Median interobserver agreement indices for areas and volumes were 
Area  MTT  : 68%, Area  CBV  : 90%, and Volume  INFARCT :  80%.
  S t a t i s t i c s  
  Data were analyzed with SPSS version 17 (SPSS Inc., Chicago, Ill., USA). Pearson correla-
tion coefficients and 2-tailed significance levels were calculated in all correlation analyses. 
Receiver-operating characteristic curves (ROC) were computed and Youden indices were eval-
uated to select optimal threshold values for imaging parameters to predict dichotomized good 
clinical outcome. After the dichotomization of the imaging parameters based on the threshold 
values, the data were cross tabulated and significance levels were calculated using Fisher’s exact 
test. Differences between correlation coefficients and ROC area under the curves (AUCs) were 
studied with Steiger’s Z test and the Hanley-McNeil procedure, respectively. Sensitivity, speci-
ficity, and confidence interval calculations were performed using standard procedures. In the 
text and the illustrations, the following notation is used to denote the level of statistical sig-
nificance:   *  p   !   0.05,   *  *  p   !   0.01 and   *  *  *  p   !   0.001. If p   6   0.01, the precise p value is given.
  R e s u l t s  
  Baseline Characteristics and Validation of the Scoring System 
  The median age of the patients was 71 years (interquartile range 58–80 years, 42 female). 
Based on the clinical features and the imaging studies, in 11 of the 92 patients evaluated, the 
ischemic episode involved the posterior circulation (8 cases of thrombosis of the basilar ar-
tery). The rest of the episodes were considered to involve the anterior circulation. The throm-
bosis could be demonstrated with CTA in 37 cases (45% of the CTA studies and 40% of all 
patients). In 40 (56%) of the 72 patients evaluated with CTP, a perfusion defect could be de-
tected in the ASPECTS planes. An additional 6 perfusion defects were found outside the 
 ASPECTS planes. A perfusion pattern implying acute ischemia could be detected in half of the 
cases involving the posterior circulation when CTP was performed. In total, a perfusion defect 
could be demonstrated in 64% of the CTP studies (50% of all patients). The median NIHSS on 
admission was 7 points (56.0% had NIHSS   !  8, 18.7% had NIHSS   1  15, interquartile range 
4–12), and 24 h later the median NIHSS was 2 points. The median mRS was 1 point preictal-
ly and 2 points 3 months later. The median change in mRS (     mRS) was 1 point. 74.4% of the 
patients experienced a favorable clinical outcome at 3 months (mRS  ^ 2). At 24 h, a local hem-
orrhagic complication (HI1, HI2, PH1, or PH2) was detected in 6 cases (6.5%), and 4 patients 
(4.4%) had parenchymal hemorrhage distant to the site of the infarct (PHr1 or PHr2). In order 11
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to validate the ASPECTS scoring method, we studied the correlations between CTP and 
NCCT ASPECTS, and the area and the volumetric data acquired from the perfusion maps and 
the NCCT images. ASPECTS for CBV and MTT were inversely correlated with the perfusion 
defect areas with r = –0.87 *  *  *  and r = –0.91 *  *  * , respectively. The correlation between the CTP 
ASPECTS mismatch and the measured mismatch area was r = 0.77 *  *  * . As expected, the infarct 
volume correlated with      mRS (r = 0.54  *  *  *  ) as did NIHSS on admission (r = 0.35  *  * ).
    CTP ASPECTS Parameters Correlate with Final Infarct Volume and Clinical Outcome 
  In order to assess the prognostic performance, we studied the correlations between dif-
ferent ASPECTS parameters, the final infarct volume, and the clinical outcome, which we 
measured with      mRS. First, we studied the overall performance of the ASPECTS scoring 
method systematically applied to all patients identified as candidates for thrombolytic ther-
apy based on clinical features, including patients with a subsequently diagnosed posterior 
circulation stroke (  table 1  , ‘all patients’). The final infarct volume correlated inversely with 
all ASPECTS, with the 24-hour follow-up NCCT having the highest correlation, as expected. 
Also the other scores displayed statistically significant correlations in the order CBV   1  
NCCT  0 h   1  MTT, with NCCT  0 h  and MTT having close to equal correlation coefficients. This 
pattern is reflected in the clinical outcome, where the correlations were ordered NCCT  24 h    1  
CBV   1   MTT   1   NCCT 0 h  , with CBV having a correlation coefficient almost equal to that of 
NCCT  24 h . In general, the correlations between ASPECTS and    mRS were weaker than those 
between ASPECTS and the infarct volume but still highly statistically significant. This pat-
Table 1. C  orrelations between the NCCT and CTP ASPECTS scores and the final infarct volume and the 
clinical outcome ( mRS) for all patients, patients with anterior circulation ischemia, and patients with 
CTP ASPECTS mismatch
Infarct volume    mRS
corr. coeff. vs. NCCT0 h corr  . coeff. vs. NCCT0 h
All patients (n = 92 for NCCT and n = 72 for CTP)
NCCT0 h r = –0.56*** – r = –0.25* –
MTT r = –0.56*** p = 1.0 r = –0.34** p = 0.40
CBV r = –0.69*** p = 0.07 r = –0.48*** p = 0.01*
NCCT24 h r = –0.82*** p < 0.001*** r = –0.49*** p = 0.01*
Anterior circulation (n = 81 for NCCT and n = 66 for CTP)
NCCT0 h r = –0.57*** – r = –0.34** –
MTT r = –0.58*** p = 0.91 r = –0.43*** p = 0.41
CBV r = –0.70*** p = 0.08 r = –0.55*** p = 0.02*
NCCT24 h r = –0.85*** p < 0.001*** r = –0.65*** p < 0.001***
Patients with CTP ASPECTS mismatch (n = 36)
NCCT0 h r = –0.55** – r = –0.39* –
MTT r = –0.48** p = 0.63 r = –0.57*** p = 0.12
CBV r = –0.66*** p = 0.33 r = –0.69*** p = 0.01*
NCCT24 h r = –0.84*** p = 0.003** r = –0.85*** p < 0.001***
The   final infarct volume and the clinical outcome correlated inversely with all ASPECTS scores, with 
the 24-hour follow-up NCCT having the highest correlation. All the correlation coefficients (corr. coeff.) 
were statistically significant. The correlations between the MTT and CBV ASPECTS scores and the clin-
ical outcome are stronger than the correlation of the admission NCCT score and the clinical outcome, 
suggesting that CTP parameters may better classify reversible and non-reversible ischemia. However, only 
the CBV score displayed a statistically significant difference (p < 0.05) from the admission NCCT score 
in all the subgroups (vs. the NCCT0 h columns). * p < 0.05; ** p < 0.01; *** p < 0.001.12
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tern is mostly due to the inclusion of the ischemic events of the posterior circulation in the 
analysis, as the prognosis of these events is generally worse and ASPECTS is designed to de-
tect disturbances in the anterior circulation. When only anterior circulation events are in-
cluded in the analysis, the correlations between ASPECTS and      mRS are strengthened, 
while the order remains unchanged (  table 1  , ‘anterior circulation’).
    CTP ASPECTS mismatch gives a single-digit estimate of the extent of reversible isch-
emia ( fig. 1 ). In our data, a mismatch was present in 36 cases (39%). In an additional 4  patients, 
a perfusion mismatch was present in the ASPECTS planes but not within any ASPECTS sub-
territory. In the ASPECTS mismatch subgroup, the correlations between ASPECTS and the 
clinical outcome were higher than in the case of all patients or all anterior circulation events, 
while the correlations between ASPECTS and infarct volume remained similar (  table 1  , ‘pa-
tients with CTP ASPECTS mismatch’).
  Overall, the correlations between the MTT and CBV scores and the clinical outcome are 
stronger than the correlation of the admission NCCT score and the clinical outcome, sug-
gesting that CTP parameters may better classify reversible and non-reversible ischemia. 
However, only the CBV score displayed a statistically significant difference (p   !   0.05) from 
the admission NCCT score in all the subgroups studied (  table 1  ).
    CTP ASPECTS Mismatch Identifies Potentially Salvageable Ischemic Tissue 
  In   figure 2  , the MTT, CBV, and NCCT  24 h   ASPECTS scores and      mRS are plotted for 
each of the 36 patients with a CTP ASPECTS mismatch and sorted according to the NCCT  24 h   
ASPECTS in descending order along the x-axis. Essentially, MTT and CBV provide the low-
er and upper limits for NCCT  24 h  , thus defining the spectrum of possible outcomes. The 
     mRS curve traces the contour of all the other curves; it lies most closely to the NCCT  24 h  
curve, which can be expected considering the results of the correlation analysis.
    A mismatch between the NCCT  24 h   and the MTT ASPECTS scores can be used to esti-
mate the amount of tissue salvaged, as MTT gives an estimate on the amount of tissue at risk 
and NCCT  24 h   depicts the size of the actual infarct. Thus, this mismatch parameter can be 
used as a surrogate for vessel recanalization. Dichotomizing    mRS with the condition    mRS 
  ^  1 to signify good clinical outcome, the lowest statistically significant threshold for the 
MTT-NCCT  24 h   ASPECTS mismatch that predicted good clinical outcome was 2 (p = 0.04). 
Using this threshold as an indicator for total or partial vessel recanalization, in the subgroup 
of patients with MTT-NCCT  24 h   ASPECTS mismatch   6  2 (n = 17), this parameter and CTP 
ASPECTS mismatch are highly correlated (r = 0.83  *  *  *  ) and have a strong linear relationship 
(R  2   = 0.70,   fig. 3  ). Overall, these findings suggest that the CTP ASPECTS mismatch ade-
quately predicts the amount of potentially salvageable ischemic brain tissue.
  CBV  ASPECTS   6  7 Identifies Patients with Good Clinical Outcome 
  Table 2  demonstrates the thresholds for good clinical outcome (   mRS  ^ 1) for the CTP 
and NCCT ASPECTS scores derived from ROC. Overall, the most robust predictor of a 
good clinical outcome was the 24-hour follow-up NCCT score  6 8, which had 94% sensitiv-
ity and 65% specificity. However, CBV   6  7 performed well in identifying patients who had 
good clinical outcome and who potentially benefited from thrombolytic therapy. This 
threshold had 100% sensitivity, 44% specificity, and no patients with good clinical outcome 
in the CBV   !  7 partition. The thresholds MTT   6  4 (AUC = 0.68) and NCCT  0 h    6  10 (AUC = 
0.66), although statistically robust, were outperformed by CBV   6  7 (AUC = 0.72). The dif-
ferences between AUCs did not yield statistical significance. However, in the case of MTT 
and NCCT  0 h , the AUCs were below the 0.70 threshold, which is often considered as a cutoff 
value for an adequately performing diagnostic test. Patients with thrombosis of the basilar 
artery in the admission CTA were excluded from the analysis.13
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  Fig. 2.   The MTT, CBV, and NCCT  24 h   ASPECTS scores and      mRS are plotted for each of the 36 patients 
with a CTP ASPECTS mismatch   1  0 according to the NCCT  24 h   ASPECTS in descending order along the 
x-axis. The      mRS curve traces the contour of all the other curves; it lies most closely to the NCCT  24 h  
curve. Essentially, MTT and CBV provide the lower and upper limits for NCCT  24 h  , thus defining the 
spectrum of possible outcomes. 
  Fig. 3.   The lowest statistically significant threshold for the MTT-NCCT  24 h   ASPECTS mismatch that pre-
dicted good clinical outcome was 2. Using this threshold as a marker indicating total or partial vessel re-
canalization, in the subgroup of patients with MTT-NCCT  24 h  ASPECTS mismatch  6 2 (n = 17), this mis-
match and CTP ASPECTS mismatch are highly correlated (r = 0.83  *  *  *  ) and have a strong linear relation-
ship (R  2   = 0.70). In the case of the outlier in the top left corner of the graph, the recanalization was partial 
or too late, allowing part of the tissue at risk to become infarcted, while the rest of the tissue at risk was 
salvaged. 14
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  Discussion 
  We set off to study the performance of different quantitative parameters obtained using 
CTP ASPECTS that potentially have an impact on the choice of treatment in acute stroke. 
With 16- and 64-slice scanners, the axial dimension of the imaging volume is limited
to 20–80 mm depending on the protocol used. This is not enough to cover the whole brain. 
Further, exact volumetric analysis of the perfusion maps requires user supervision, espe-
cially in the case of CBV, and is too slow a procedure to be used in the context of acute stroke 
imaging, which requires rapid online interpretation of the images. Thus, applying the 
  ASPECTS scoring system to the perfusion images becomes an attractive option   [12] .
    We decided to use the difference between the postictal and the preictal mRS as the indi-
cator of good clinical outcome, as this better reflects the disease load inflicted by the current 
episode. As expected from the definitions,      mRS and 3-month mRS are highly correlated
(r = 0.85 *  *  * ). Since poor preictal functional status is essentially a contraindication to throm-
bolytic therapy, the offset between      mRS and 3-month mRS is generally very small or non-
existent. The median preictal mRS in our research population was 1. The threshold for good 
clinical outcome was chosen to be     mRS   ^  1 in order to maintain comparability to the tra-
ditional 3-month mRS   ^ 2  threshold.
    All patients who received intravenous thrombolytic therapy in a period of 1 year were 
included in the baseline analysis regardless of the vascular territory affected in order to gain 
a realistic idea of the performance of the multimodal CT evaluation of stroke in a clinical 
setting. A perfusion defect could be detected in 50% of these patients, implying that with the 
technology used, a CT perfusion study could have an impact on half of the positive throm-
bolytic treatment decisions at the maximum. In total, 87% of the perfusion defects were pres-
ent in either or both of the two ASPECTS planes. Those located outside the ASPECTS planes 
were detected by the 64-slice scanner in all but 1 case. The acute ischemic lesions that escape 
detection by CTP are mostly lacunar processes or are localized infratentorially or cranially 
to the perfusion study volume   [17] .
    We hypothesized that CTP ASPECTS parameters predict the clinical outcome of pa-
tients who receive intravenous thrombolytic therapy better than the traditional admission 
NCCT. Correlation analyses with all patients and relevant subgroups support this hypoth-
esis, as the CTP parameters correlate more closely with the clinical outcome when compared 
Table 2.   Threshold values for dichotomized NCCT and CTP ASPECTS parameters that best differentiate 
between good ( mRS ≤1) and bad clinical outcome
Threshold Good 
outcome
p
value
RR
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
AUC
CBV ≥7 vs. <7 74 vs. 0% <0.001 n/a 1.00 (0.93–1.00) 0.44 (0.25–0.66) 0.72
MTT ≥4 vs. <4 68 vs. 6% <0.001 11.5 (2.9–45.6) 0.92 (0.81–0.97) 0.5 (0.29–0.71) 0.68
NCCT0 h ≥10 vs. <10 65 vs. 11% 0.01 6.0 (3.2–11.3) 0.86 (0.75–0.92) 0.45 (0.26–0.66) 0.66
NCCT0 h ≥7 vs. <7 75 vs. 1% 0.04 62.0 (8.8–436.7) 0.98 (0.92–1.00) 0.15 (0.05–0.36) 0.66
NCCT24 h ≥8 vs. <8 71 vs. 5% <0.001 27.4 (7.0–107.5) 0.94 (0.85–0.98) 0.65 (0.43–0.82) 0.83
R  OC were devised to find the optimal threshold values. Overall, the most robust predictor of good 
clinical outcome was the 24-hour follow-up NCCT score ≥8. CBV ≥7 performed well in identifying 
  patients who had good clinical outcome and who potentially benefited from thrombolytic therapy. The 
differences between the AUCs did not yield statistical significance for the admission imaging studies 
(CBV, MTT, and NCCT0 h). Patients with thrombosis of the basilar artery were excluded from the analysis. 
RR = Risk ratio; CI = confidence interval; n/a = not available.15
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to the NCCT findings (  table 1  ). However, only CBV displayed a statistically significant dif-
ference from NCCT, while MTT did not reach statistical significance. This is probably due 
to the heterogeneity introduced by cases in which thrombolytic therapy was effective and the 
MTT defect was totally or partially reversed. There was no statistically significant difference 
in the correlations between the admission CTP and NCCT parameters and the total infarct 
volume. This finding can be expected as the strength of the correlation between the infarct 
volume and the clinical outcome was only moderate (r = 0.54  *  *  *  ), which probably reflects 
the presence of strategic infarcts that have a relatively small volume but have a considerable 
impact on the clinical outcome and often escape detection by the follow-up NCCT.
    Optimally, the decision of administering thrombolytic therapy is based on the amount 
of salvageable brain tissue present. In the MCA region, this tissue volume is correlated with 
CTP ASPECTS mismatch   [16]  . In total, 39% of the patients presented with such a mismatch. 
We demonstrated that in patients who received thrombolytic therapy CTP ASPECTS mis-
match adequately identifies the amount of potentially salvageable tissue (  fig. 2  ,   3  ). However, 
small mismatches are difficult to interpret because of noise introduced by biological hetero-
geneity and errors in image analysis. In our data, a mismatch  6 2 was linked with good clin-
ical outcome. A larger sample size is needed for a more accurate analysis.
    Other notable limitations of this study are its retrospective design and non-excellent in-
terobserver agreement in some imaging parameters, which, however, is comparable to that 
previously reported   [13] .
    Finally, in the footsteps of previous investigators, we identified threshold values for di-
chotomized NCCT and CTP ASPECTS parameters that would best differentiate between 
good and bad clinical outcome. Our approach emphasized the sensitivity of identifying pa-
tients with potentially good outcome. While a statistically robust threshold could be devised 
for all the parameters studied, the threshold that performed best at presentation was CBV  6 7, 
which is in accordance with previous findings   [12–15]  . However, thresholds 6 and 8 per-
formed almost equally well, implying that relying on a single threshold value in decision mak-
ing is probably ill advised. We also tested the established admission NCCT ASPECTS   6 7 
threshold. This threshold proved to be very unspecific (Specificity 15%), which is to be ex-
pected as there were only patients who received thrombolytic therapy in our study population.
    In conclusion, advances in the management of acute ischemic stroke and medical imag-
ing and the extension of the time window for thrombolytic therapy are creating pressure to 
replace the rigid one-third MCA rule and non-contrast-enhanced CT ASPECTS thresholds 
in selecting patients to receive thrombolytic therapy with a shift toward identifying patients 
with potentially salvageable ischemic brain tissue. Our data suggest that parameters derived 
using ASPECTS scoring of CT perfusion images, especially the CTP ASPECTS mismatch, 
can in part answer these demands. Further, on admission, the ASPECTS of the CBV map 
correlates more strongly with clinical outcome than the NCCT ASPECTS.
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